Literature DB >> 2555638

N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue.

R Camble1, R Cotton, A S Dutta, A Garner, C F Hayward, V E Moore, P B Scholes.   

Abstract

The GRP receptor mediated growth response in Swiss 3T3 cells has been used to identify BN/GRP antagonists. Analysis of bombesin antagonism by substance P analogues and by truncated GRP analogues revealed that deletion of the C-terminal methionine residue was important for antagonism. Des-Met analogues showing potent antagonist activity in the in vitro 3T3 system (IC50 approximately 2nM) were synthesized. Further structural modification of these peptides led to the identification of (CH3)2CHCO-His-Trp-Ala-Val-D-Ala-His-Leu-NHCH3 (ICI 216140) which reduced bombesin-stimulated rat pancreatic amylase secretion to basal levels when administered subcutaneously at 2.0 mg per kg.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555638     DOI: 10.1016/0024-3205(89)90417-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.

Authors:  K Szepeshazi; A V Schally; G Halmos; N Lamharzi; K Groot; J E Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

2.  Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.

Authors:  J Staley; D H Coy; R T Jensen; T W Moody
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

Review 3.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

Review 4.  Therapeutic potential of growth factors and their antagonists.

Authors:  A Garner
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.